Jivi (damoctocog alfa pegol) Patient Assistance Program
Don’t let the high cost of brand extended half-life recombinant factor VIII disrupt your hemophilia A treatment. We help eligible patients access Jivi (damoctocog alfa pegol) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
Key Takeaways:
- Jivi (damoctocog alfa pegol) is FDA-approved for treatment and prophylaxis of bleeding in previously treated adults and adolescents (12 years and older) with hemophilia A (congenital factor VIII deficiency). PEGylated recombinant factor VIII (BDD) — extended half-life allows less frequent prophylaxis dosing (2–3 times weekly) than standard-half-life factor VIII.
- Without assistance, Jivi costs commonly run approximately $15,000–$25,000+ per month for prophylaxis (weight and dosing-frequency dependent).
- Through AffordMyPrescriptions, qualifying patients can access Jivi for a flat $69.95 per month.
- Hemophilia A landscape: standard-half-life recombinant factor VIII (Advate, Recombinate, Kogenate FS, Xyntha, Novoeight); extended-half-life factor VIII (Adynovate, Eloctate, Kovaltry, Nuwiq, Afstyla, Esperoct, Jivi, Altuviiio); non-factor therapies (Hemlibra — emicizumab bispecific antibody, revolutionizing prophylaxis with weekly-to-monthly SC dosing; Roctavian gene therapy for adults, 2022). Novoseven and Feiba for hemophilia A with inhibitors. Comprehensive Hemophilia Treatment Centers. National Hemophilia Foundation resources.
What is Jivi Prescription Assistance Program?
The Jivi Patient Assistance Program helps eligible patients access this extended half-life factor VIII at little or no cost when meeting income, insurance, and clinical criteria.
At AffordMyPrescriptions, our Patient Advocates handle the entire Jivi PAP enrollment for a flat $69.95 per month — so you never face a gap in Jivi hemophilia A therapy.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your Jivi enrollment — so you never face a gap in your hemophilia A treatment.
Pharmacy Price Comparison
- Without assistance, Jivi costs tens of thousands per month. A Patient Assistance Program can offset costs if you qualify:
| PHARMACY | PRICE (30-DAY) WITH BEST COUPONS | YOU SAVE W/ US |
|---|---|---|
| Std half-life FVIII alt | ~$15,000/mo | Standard FVIII alt |
| Specialty pharmacy | ~$20,000/mo | Save substantially |
| Hemophilia Treatment Center | ~$18,000/mo | Save substantially |
| Hospital pharmacy | ~$25,000/mo | Save substantially |
| 340B-eligible institution | ~$15,000/mo | Save substantially |
| Hemlibra (non-factor alt) | ~$40,000/mo | Alt non-factor prophylaxis |
*Retail prices are estimates based on public data and vary by pharmacy. Coupon prices from GoodRx and SingleCare as of April 2026. AffordMyPrescriptions Advocacy Service bypasses pharmacy pricing entirely by using the manufacturer’s assistance program to secure your Jivi — independent of dosage or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Jivi Prescription Program?
The Jivi Patient Assistance Program is free to apply. Our $69.95 per month covers full advocacy. Hemophilia care is best delivered at Hemophilia Treatment Centers with multidisciplinary teams. Non-factor therapies (Hemlibra) revolutionized hemophilia A prophylaxis.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for Jivi assistance.
We Advocate
Our specialists gather documentation, complete applications, and coordinate with your prescriber and the assistance program.
Receive Medication
Once approved, your Jivi is delivered through the assistance program while we manage refills and annual renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Jivi:
Limitations of Coupons
Prices fluctuate — savings aren’t guaranteed month-to-month
Copay accumulators may prevent savings from counting toward your deductible
Coupon cards expire and require constant renewal
Still $15,000–$25,000 per month even with the best discount
Cannot be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
Medication supplied directly through the assistance program
We manage all paperwork, refills, and annual renewals
Medicare Part D patients accepted
If denied, we explore alternative savings paths on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Jivi assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Jivi Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Understanding Jivi:
Jivi is a PEGylated recombinant factor VIII — its extended half-life enables less-frequent prophylaxis dosing than standard-half-life factor VIII. A continued key option for hemophilia A patients preferring a factor replacement approach.
How It Works:
Hemophilia A is a congenital deficiency of coagulation factor VIII — X-linked recessive inheritance, mostly affecting males. It causes bleeding into joints (hemarthrosis), muscles, and other tissues. Severe hemophilia (<1% FVIII) causes spontaneous bleeding; prophylaxis prevents joint damage and improves quality of life. Recombinant factor VIII replaces the missing coagulation factor. The standard half-life of ~8–12 hours requires prophylaxis 3+ times weekly. PEGylation (Jivi) prolongs the half-life to enable 2–3 times weekly prophylaxis. Other extended half-life mechanisms include Fc-fusion (Eloctate) and VWF-Xten fusion (Altuviiio). Non-factor therapies (Hemlibra — emicizumab bispecific antibody) bind factor IXa and factor X to substitute for factor VIII function — with SC dosing weekly to monthly.
Form and Use:
Jivi IV infusion. Individualized dosing based on weight, FVIII half-life pharmacokinetic study, bleeding pattern, and prophylaxis regimen. Given at home or a hemophilia treatment center. Individualized prophylaxis regimen through a Hemophilia Treatment Center.
Generic Availability:
No generic Jivi. Extensive hemophilia A therapies: standard-half-life factor VIII (Advate, Recombinate, Kogenate FS, Xyntha, Novoeight); extended-half-life factor VIII (Adynovate, Eloctate, Kovaltry, Nuwiq, Afstyla, Esperoct, Jivi, Altuviiio — Altuviiio has the longest half-life of factor VIII products). Non-factor therapies (Hemlibra — emicizumab bispecific antibody, weekly-to-monthly SC dosing, revolutionizing hemophilia A prophylaxis). Gene therapy (Roctavian — valoctocogene roxaparvovec — 2022 FDA approval for severe hemophilia A adults). Bypassing agents for inhibitors (Novoseven, Feiba). Comprehensive Hemophilia Treatment Centers coordinate multidisciplinary care. National Hemophilia Foundation and Hemophilia Federation of America provide resources.
Warnings:
Development of inhibitors (neutralizing antibodies against factor VIII — screen periodically), hypersensitivity reactions (including anaphylaxis), embryo-fetal considerations. Other: infusion reactions, headache, injection site reactions. Comprehensive Hemophilia Treatment Center care is essential for monitoring, individualized prophylaxis regimens, and bleeding episode management.
FAQ (Frequently Asked Questions)
How much does Jivi cost without insurance?
$15,000–$25,000+ per month depending on weight and dosing frequency. Hemophilia care is among the most expensive in medicine — Patient Assistance Programs are essential.
How is Jivi different from other factor VIII products?
Jivi is PEGylated recombinant B-domain deleted factor VIII — PEGylation extends the half-life vs standard factor VIII, enabling less frequent prophylaxis dosing (2–3x weekly vs 3+x weekly). Other extended half-life products use different mechanisms (Fc-fusion in Eloctate, VWF-Xten fusion in Altuviiio). Altuviiio currently has the longest half-life factor VIII product.
How does Jivi compare to Hemlibra?
Different classes. Jivi is factor VIII replacement (IV). Hemlibra (emicizumab) is a bispecific antibody that binds factor IXa and factor X to substitute for factor VIII function — with SC dosing weekly to monthly. Hemlibra revolutionized hemophilia A prophylaxis convenience. It is not for treatment of active bleeding (factor VIII replacement or bypassing agents are still needed for breakthrough bleeds). Choice depends on individual factors, inhibitor status, and preferences.
What is gene therapy for hemophilia A?
Roctavian (valoctocogene roxaparvovec — 2022 FDA approval) is a one-time gene therapy for severe hemophilia A adults — delivering the factor VIII gene via an AAV5 vector for sustained factor VIII production. Not appropriate for all patients (contraindications, immune considerations, inhibitor status). Discuss with a Hemophilia Treatment Center.
Should I receive care at a Hemophilia Treatment Center?
Yes — Comprehensive Hemophilia Treatment Centers provide multidisciplinary care including hematology, orthopedics, physical therapy, social work, genetic counseling, and coordinated pharmacy. HTC care is associated with improved outcomes. The National Hemophilia Foundation maintains a directory of HTCs.
Take Control of Your Medication Costs
Hemophilia A treatment is among the most expensive in medicine — accessible therapy is critical. Our advocacy team is ready — $69.95 per month, or free if we cannot help.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.